These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6644329)

  • 1. Increased manganese level in spinal cords of amyotrophic lateral sclerosis determined by radiochemical neutron activation analysis.
    Miyata S; Nakamura S; Nagata H; Kameyama M
    J Neurol Sci; 1983 Oct; 61(2):283-93. PubMed ID: 6644329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of manganese in tissues by neutron activation analysis using an antimony pentoxide column.
    Miyata S; Nakamura S; Toyoshima M; Hirata Y; Saito M; Kameyama M; Matsushita R; Koyama M
    Clin Chim Acta; 1980 Oct; 106(3):235-42. PubMed ID: 7418226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of manganese concentrations in the spinal cords from amyotrophic lateral sclerosis patients by inductively coupled plasma emission spectroscopy.
    Kihira T; Mukoyama M; Ando K; Yase Y; Yasui M
    J Neurol Sci; 1990 Sep; 98(2-3):251-8. PubMed ID: 2243233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The distribution of manganese in the spinal cord of amyotrophic lateral sclerosis -- determination of manganese by neutron activation analysis (author's transl)].
    Miyata S; Nakamura S; Toyoshima M; Kameyama M; Koyama M
    Rinsho Shinkeigaku; 1980 Nov; 20(11):917-23. PubMed ID: 7249473
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of the Ca/P atomic ratio in the spinal cord of patients with amyotrophic lateral sclerosis by neutron activation and X-ray fluorescence analysis].
    Mizumoto Y; Iwata S; Sasajima K; Yoshida S; Yoshimasu F; Yase Y
    Radioisotopes; 1983 Nov; 32(11):551-4. PubMed ID: 6675059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Free amino acid contents in the spinal cord of amyotrophic lateral sclerosis].
    Fujita K; Nagata Y; Honda M
    Rinsho Shinkeigaku; 1993 Sep; 33(9):985-7. PubMed ID: 7905368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of immunoreactive thyrotropin-releasing hormone in spinal cord of patients with amyotrophic lateral sclerosis.
    Mitsuma T; Nogimori T; Adachi K; Mukoyama M; Ando K
    Am J Med Sci; 1984; 287(2):34-6. PubMed ID: 6424472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alpha particle excited X-ray fluorescence analysis for trace elements in cervical spinal cords of amyotrophic lateral sclerosis (author's transl)].
    Mizumoto Y; Iwata S; Sasajima K; Yase Y; Yoshida S
    Radioisotopes; 1980 Dec; 29(12):585-9. PubMed ID: 7244303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis.
    Dawson G; Stefansson K
    J Neurosci Res; 1984; 12(2-3):213-20. PubMed ID: 6502751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid.
    Jackson IM; Adelman LS; Munsat TL; Forte S; Lechan RM
    Neurology; 1986 Sep; 36(9):1218-23. PubMed ID: 3092130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nerve tissue changes in ALS (amyotrophic lateral sclerosis) and neutron activation analysis].
    Yase Y
    Nihon Rinsho; 1977 Nov; 35(11):4037-43. PubMed ID: 599683
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on amyotrophic lateral sclerosis by neutron activation analysis.
    Yoshimasu F; Uebayashi Y; Yase Y; Iwata S; Sasajima K
    Folia Psychiatr Neurol Jpn; 1976; 30(1):49-55. PubMed ID: 955523
    [No Abstract]   [Full Text] [Related]  

  • 13. [X-ray microanalysis of amyotrophic lateral sclerosis. (1) Metal distribution compared with neuropathological findings in the cervical spinal cord].
    Yoshida S
    Rinsho Shinkeigaku; 1977 May; 17(5):299-309. PubMed ID: 560276
    [No Abstract]   [Full Text] [Related]  

  • 14. Glycine levels in the degenerated human spinal cord.
    Boehme DH; Marks N; Fordice MW
    J Neurol Sci; 1976 Mar; 27(3):347-52. PubMed ID: 1262898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of brain-derived neurotrophic factor in the spinal cords of amyotrophic lateral sclerosis and non-amyotrophic lateral sclerosis patients.
    Kawamoto Y; Nakamura S; Akiguchi I; Kimura J
    J Neuropathol Exp Neurol; 1998 Sep; 57(9):822-30. PubMed ID: 9737545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model.
    Arima H; Omura T; Hayasaka T; Masaki N; Hanada M; Xu D; Banno T; Kobayashi K; Takeuchi H; Kadomatsu K; Matsuyama Y; Setou M
    Neuroscience; 2015 Jun; 297():127-36. PubMed ID: 25841322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative damage to proteins in the spinal cord in amyotrophic lateral sclerosis (ALS).
    Niebrój-Dobosz I; Dziewulska D; Kwieciński H
    Folia Neuropathol; 2004; 42(3):151-6. PubMed ID: 15535033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Similarities in calcium and magnesium metabolism between amyotrophic lateral sclerosis and calcification of the spinal cord in the Kii Peninsula ALS focus].
    Yasui M; Yoshida M; Tamaki T; Taniguchi Y; Ota K
    No To Shinkei; 1997 Aug; 49(8):745-51. PubMed ID: 9282369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factor receptors in amyotrophic lateral sclerosis.
    Adem A; Ekblom J; Gillberg PG
    Mol Neurobiol; 1994; 9(1-3):225-31. PubMed ID: 7888098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of change in indoleamine metabolism in spinal cord of patients with amyotrophic lateral sclerosis.
    Ohsugi K; Adachi K; Mukoyama M; Ando K
    Neurosci Lett; 1987 Aug; 79(3):351-4. PubMed ID: 2443876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.